Santiago Gallardo Johnson

FDA investigator

Appears on 18 documents from 2017 to 2023, mostly at sites in California. Most often cites production record review (21 CFR 211.192).

18
Documents on file
3.4
Observations per 483
2017
First seen
2023
Most recent

What they cite most

From 62 observations

Activity by year

2017: 2, 2018: 1, 2019: 6, 2020: 1, 2021: 3, 2022: 4, 2023: 1

Where

California 14 · Japan 3 · Colorado 1

Is Santiago Gallardo Johnson coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

18 documents, newest first
FirmOpen
483 Societal CDMO San Diego, LLCJan 25, 2023 · San Diego, California
483 Hyland's Consumer Health Inc.Nov 29, 2022 · Los Angeles, California
483 Daito Pharmaceutical Co., LtdSep 16, 2022 · Toyama-City, Japan
483 Ishihara Sangyo Kaisha, Ltd.Sep 9, 2022 · Yokkaichi, Japan
483 Meiji Seika Pharma Co., Ltd. 2890 Kitagata, Kitagata-Cho, Motosa-GunSep 2, 2022 · Gifa, Japan
483 Teva Parenteral Medicines, Inc.Aug 20, 2021 · Irvine, California
483 Ajinomoto Althea, Inc.May 25, 2021 · San Diego, California

About this profile

What does Santiago Gallardo Johnson inspect?

Santiago Gallardo Johnson appears on 18 documents on file covering 15 sites, mostly in California.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.22 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Santiago Gallardo Johnson is dated Jan 25, 2023.